Bay Street News, January 3rd, 2019

NEW YORK, Jan. 03, 2019 (GLOBE NEWSWIRE) — BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem […]

VANCOUVER, British Columbia, Jan. 03, 2019 (GLOBE NEWSWIRE) — RavenQuest BioMed Inc. (the “Company” or “RavenQuest”) – (CSE: RQB, OTCQB: […]

MISSION VIEJO, Calif., Jan. 03, 2019 (GLOBE NEWSWIRE) — The Ensign Group, Inc. (NASDAQ: ENSG), the parent company of the […]

Nicole Vitullo Brings Public Company Investment and Leadership Expertise as the next Chair of Achillion Board of Directors NEW HAVEN, […]

PHOENIX, Jan. 03, 2019 (GLOBE NEWSWIRE) — INSYS Therapeutics, Inc. (NASDAQ: INSY), a leader in the development, manufacture and commercialization […]

RANCHO CUCAMONGA, Calif., Jan. 03, 2019 (GLOBE NEWSWIRE) — Amphastar Pharmaceuticals, Inc., (NASDAQ: AMPH) announced today that Primatene® MIST has […]

TORONTO, Jan. 03, 2019 (GLOBE NEWSWIRE) — Honey Badger Exploration Inc. (TSX-V: TUF) (“Honey Badger” or the “Company”) announces that […]

TORONTO, Jan. 03, 2019 (GLOBE NEWSWIRE) — Red Pine Exploration Inc. (TSX-V: RPX) (“Red Pine” or the “Company”) announces new […]

NEW YORK, Jan. 03, 2019 (GLOBE NEWSWIRE) — Cowen Inc. (NASDAQ: COWN) (“Cowen” or the “Company”) today announced that it […]

Lausanne, Switzerland, January 3, 2019 – AC Immune SA (NASDAQ: ACIU), a Swiss-based, clinical-stage biopharmaceutical company with a broad pipeline […]